Canntab Therapeutics Limited TBF1.F Stock
Canntab Therapeutics Limited Price Chart
Canntab Therapeutics Limited TBF1.F Financial and Trading Overview
| Canntab Therapeutics Limited stock price | 0.0005 EUR |
| Previous Close | 0.0005 EUR |
| Open | 0.0005 EUR |
| Bid | 0.0005 EUR x 0 |
| Ask | 0.01 EUR x 0 |
| Day's Range | 0.0005 - 0.01 EUR |
| 52 Week Range | 0.0005 - 0.17 EUR |
| Volume | 4.16K EUR |
| Avg. Volume | 243 EUR |
| Market Cap | 19.45K EUR |
| Beta (5Y Monthly) | 0.830468 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TBF1.F Valuation Measures
| Enterprise Value | 2.29M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.26476672 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 31.137 |
| Enterprise Value/EBITDA | -0.755 |
Trading Information
Canntab Therapeutics Limited Stock Price History
| Beta (5Y Monthly) | 0.830468 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.17 EUR |
| 52 Week Low | 0.0005 EUR |
| 50-Day Moving Average | 0.0015 EUR |
| 200-Day Moving Average | 0.003225 EUR |
TBF1.F Share Statistics
| Avg. Volume (3 month) | 243 EUR |
| Avg. Daily Volume (10-Days) | 415 EUR |
| Shares Outstanding | 38.91M |
| Float | 33M |
| Short Ratio | N/A |
| % Held by Insiders | 13.74% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:200 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4731.089% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.60% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 73.48K EUR |
| Revenue Per Share (ttm) | 0.002 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -939011 EUR |
| EBITDA | -3028307 EUR |
| Net Income Avi to Common (ttm) | -3355501 EUR |
| Diluted EPS (ttm) | -1.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.81K EUR |
| Total Cash Per Share (mrq) | 0 EUR |
| Total Debt (mrq) | 1.9M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.108 |
| Book Value Per Share (mrq) | -0.056 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1401236 EUR |
| Levered Free Cash Flow (ttm) | -612491 EUR |
Profile of Canntab Therapeutics Limited
| Country | Germany |
| State | ON |
| City | Markham |
| Address | 223 Riviera Drive |
| ZIP | L3R 5J6 |
| Phone | N/A |
| Website | https://canntab.ca |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Q&A For Canntab Therapeutics Limited Stock
What is a current TBF1.F stock price?
Canntab Therapeutics Limited TBF1.F stock price today per share is 0.0005 EUR.
How to purchase Canntab Therapeutics Limited stock?
You can buy TBF1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Canntab Therapeutics Limited?
The stock symbol or ticker of Canntab Therapeutics Limited is TBF1.F.
Which industry does the Canntab Therapeutics Limited company belong to?
The Canntab Therapeutics Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Canntab Therapeutics Limited have in circulation?
The max supply of Canntab Therapeutics Limited shares is 265.71M.
What is Canntab Therapeutics Limited Price to Earnings Ratio (PE Ratio)?
Canntab Therapeutics Limited PE Ratio is now.
What was Canntab Therapeutics Limited earnings per share over the trailing 12 months (TTM)?
Canntab Therapeutics Limited EPS is -0.06 EUR over the trailing 12 months.
Which sector does the Canntab Therapeutics Limited company belong to?
The Canntab Therapeutics Limited sector is Healthcare.